Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors

por Pulkkinen, V., Ezer, S., Sundman, L., Hagström, J., Remes, S., Söderhäll, C., Dario, G., Haglund, C., Kere, J., Arola, J.
Publicado 2014

Erratum to: “Neuropeptide S receptor 1 (NPSR1) activates cancer-related pathways and is widely expressed in neuroendocrine tumors

por Pulkkinen, V., Ezer, S., Sundman, L., Hagström, J., Remes, S., Söderhäll, C., Greco, D., Haglund, C., Kere, J., Arola, J.
Publicado 2014

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer

por Böckelman, C, Hagström, J, Mäkinen, L K, Keski-Säntti, H, Häyry, V, Lundin, J, Atula, T, Ristimäki, A, Haglund, C
Publicado 2011

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue

por Häyry, V, Mäkinen, L K, Atula, T, Sariola, H, Mäkitie, A, Leivo, I, Keski-Säntti, H, Lundin, J, Haglund, C, Hagström, J
Publicado 2010